Schizophrenia: An Update of the Selenium Deficiency Hypothesis

Journal of Orthomolecular Medicine

Volumn 11, Issue 4, 1996, Pages 211-222

  Brown Jr , James S ^a   Foster, Harold D ^b  

^a UNITED STATES MILITARY ACADEMY   (United States)

^b UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347302642     PISSN: 03170209     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Hetzel BS: The story of iodine deficiency: an international challenge in nutrition. Oxford: Oxford University Press. 1989.
2. Editorial Board: The atlas of endemic diseases and their environments in the People's Republic of China. Beijing: Science Press. 1989.
3. Donaldson J: The physiopathologic significance of manganese in brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicol, 1987; 8: 451-462.
4. Yase Y: The pathogenesis of Amyotrophic lateral sclerosis. Lancet, 1972; 2: 292-295.
5. Walker M: Excessive tissue manganese as a cause of antisocial behaviour. Townsend Letter for Doctors, 1994; 137: 1328-1334.
6. Ellis D: Environments at risk: case histories of impact assessment. Berlin: Springer-Verlag. 1989.
7. Flaten TD: Geographical associations between aluminium in drinking water and death rates with dementia (including Alzheimer's disease), Parkinson's disease and amyotrophic lateral sclerosis in Norway. Environ Geochem Health, 1990; 12(1-2): 152-167.
8. Martyn CN, Osmond C, Edwardson JA: Geographical relation between Alzheimer's disease and aluminum in drinking water. Lancet, 1989; 334: 59-62.
9. Houeland T: Aluminum and Alzheimer's disease: is there a causal connection? Environ Geochem Health, 1990; 12(1-2): 173-177.
10. Susser ES, Lin SP: Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945. Arch Gen Psychiat, 1992; 49: 983-988.
11. Foster HD: The geography of schizophrenia: possible links with selenium and calcium deficiencies, inadequate exposure to sunlight and industrialization. J Orthomolecular Med, 1988; 3(3): 135-140.
12. Foster HD: Health, Disease and the Environment. London: Belhaven Press, 1992.
13. Brown JS: Role of selenium and other trace elements in the geography of schizophrenia. Schizophrenia Bulletin, 1994; 20(2): 387-398.
14. Berry T: A selenium transport protein model of a sub-type of schizophrenia. Med Hypoth, 1994; 43: 409-414.
15. Hill AB: The environment and disease: association or causation? Proc Roy Soc Med, 1965; 58: 295-300.
16. Jones K, Moon G: Health, Disease and Society: an Introduction to Medical Geography. London: Routledge and Kegan Paul. 1987.
17. Torrey EF, Bowler A: Geographical distribution of insanity in America: evidence for an urban factor. Schizophrenia Bulletin, 1990; 16: 591-604.
18. Torrey EF: Schizophrenia and Civilization, New York: Jason Aronson. 1980.
19. Frost DV: Why the level of selenium in the food chain appears to be decreasing. In: Combs GF Jr, Spallholz JE, Levander OA, Oldfield JE (eds). Selenium in Biology and Medicine Part A. New York: Van Nostrand Reinhold. 1987: 534-547.
20. Trowell HC, Burkitt DP (eds): Western Diseases: their emergence and prevention. Cambridge, Mass.: Harvard University Press. 1981.
21. Mertz W: Selenium from a distance. In: Combs GF Jr, Spallholz JE, Levander OA, Oldfield JE (eds). Selenium in Biology and Medicine Part A. New York: Van Nostrand Reinhold. 1987: 3-8.
22. Christensen O, Christensen E: Fat consumption and schizophrenia. Acta Psychiat Scand, 1988; 78(5): 587-591.
23. Erasmus U: Fats and Oils: the complete guide to fats and oils and health and nutrition. Vancouver: Alive Books. 1986.
24. Horrobin DF: Schizophrenia: Reconciliation of the dopamine, prostaglandins, and opioid concepts and the role of the pineal. Lancet, 1979: 529-531.
25. Hong Y, Li CH, Burgess JR, et al: The role of selenium-dependent and selenium-independent glutathione peroxidases in the formation of prostaglandins F2 alpha. J Biol Chem, 1989; 264(23): 13793-13800.
26. Fujita T, Nakatani E, Funaishi N, et al: Potent inhibition of prostaglandin inactivation in rabbit gastric antral mucosal slices by selenium ions invitro. J Pharm Pharmacol, 1990; 42(9): 655-657.
27. Hampel G, Reinke M, Hren J: Prostaglandin synthesis is increased in selenium supplemented human mesangial cells despite suppression of phospholipase A2 activity. Life Sci, 1991; 49(12): 881-888.
28. Lohr JB: Oxygen radicals and psychiatric illness: some speculations. Arch Gen Psychiat, 1991; 48: 1097-1106.
29. Van der Torre HW, Veenstra J, Van de Pol H, et al: Effects of selenium supplementation on platelet function as assessed by platelet aggregation and glutathione peroxidase activity. In: Wendel A (ed). Selenium in Biology and Medicine. New York: Springer Verlag. 1989: 219-222.
30. Bryant RW, Simon TC, Bailey JM: Hydroperoxy fatty acid formation in selenium deficient rat platelets: coupling of glutathione peroxidase to the lipoxygenase pathway. Biochem Biophys Res Comm, 1983; 117: 183-189.
31. Marangos PJ, Lal H (eds): Emerging Strategies in Neuroprotection. Boston, MA: Birkhauser. 1992.
32. Schoene NW, Morris VC, Levander OA: Altered arachidonic acid metabolism in platelets and aortas from selenium deficient rats. Nutr Res, 1986; 6: 75-83.
33. Suttle NF, Jones DG: Recent developments in trace element metabolism and function: trace elements, disease resistance and immune responsiveness in ruminants. J Nutr, 1989; 119: 1055-1061.
34. Yolken RH, Torrey EF: Viruses, schizophrenia and bipolar disorder. Clin Microbiol Rev, 1995; 8: 131-145.
35. Beck ME, Shi Q, Morriss VC, et al: Rapid genomic evolution of non-viralent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nature Med, 1995; 1(5): 433-436.
36. Levander OA, Ager AL Jr, Beck MA: Vitamin E and Selenium: contrasting and interacting nutritional determinants of host resistance to parasitic and viral infections. Proc Nutr Soc, 1995; 54: 475-487.
37. Oldfield JE: The China connection. Bulletin of the Selenium-Tellurium Development Association, September, 1995: 2-3.
38. Taylor EW, Ramanathan CS: Theoretical evidence that the Ebola Virus Zaire strain may be selenium-dependent: a factor in pathogenesis and viral outbreaks? J Orthomolecular Med, 1995; 10(3): 131-138.
39. Tada K, Nogami Y, Nagashima M, et al:Trace elements in the hair of schizophrenics. Biol Psychiat, 1986; 21: 325-328.
40. Alertsen AR, Aukrust A, Skaug OE: Selenium concentration in blood and serum from patients with mental diseases. Acta Psychiat Scand, 1986; 74: 217-219.
41. Buckman TD, Kling AS, Eiduson S, et al: Glutathione peroxidase and CT scan abnormalities in schizophrenia. Biol Psychiat, 1987; 22(11): 1349-1356.
42. Osmond H, Hoffer A: massive niacin treatment in schizophrenia: Review of a nine-year study. Lancet, 1962; 1: 316-320.
43. Ban TA: Nicotinic acid in the treatment of schizophrenias:practical and theoretical considerations. Neuropsychobiol, 1975; 1: 133-145.
44. Rudin DO, Felix C (with Schraeder C): The Omega-3 Phenomenon. New York: Avon Books. 1987.
45. Vaddadi KS: Prostaglandins Medicine, 2: 22. Cited by Horrobin DF, op. cit. 530.
46. Vaddadi KS: Prostaglandins Medicine, 2: 22. Cited by Horrobin DF, op. cit. 530.
47. Torrey EF: Prevalence studies in schizophrenia. Brit J Psychiat, 1987; 150: 598-608.
48. Jablensky A: Epidemiology of schizophrenia: a European perspective. Schizophrenia Bulletin, 1986; 12: 52-73.
49. Lehtinen V, Joukamaa M, Lahtela J, et al: Prevalence of mental disorders among adults in Finland: basic results from the mini Finland health survey. Acta Psychiat Scand, 1990; 81: 418-425.
50. Alfthan G, Aro A, Hittunen JK: Supplementation of a population with selenium: reasons for action and initial experience. In: Wendal A (ed). Selenium in Biology and Medicine. New York, NY: Springer Verlag. 1989: 210-213.
51. Jorgensen PM, Mortensen PB: Incidence and other aspects of the epidemiology of schizophrenia in Denmark, 1971-1987. Brit J Psychiat, 1992; 161: 489-495.
52. Gissel-Nielsen G, Gupta UC, Lamand M, et al: Selenium in soils and plants and its importance in livestock and human nutrition. In: Brady NC (ed). Advances in Agronomy 37. Orlando, Florida: Academic Press. 1984: 398-460.
53. O'Hara: Personal communication with Brown JS Jr. 1992.
54. Watkinson JH: Prevention of deficiency in grazing animals by annual topdressing of pasture with sodium selenate. NZ Vet J, 1983; 31: 78-85.
55. Wells JE, Bushnell JA, Hornblow AR, et al: Christchurch psychiatric epidemiology study: Part 1. Methodology and lifetime prevalence for specific psychiatric disorders. Aust & NZ J Psychiat, 1989; 23: 315-326.
56. Joyce PR: Changing trends in first admissions and re-admission for mania and schizophrenia in New Zealand, 1974 to 1984. Aust & NZ J Psychiat, 1987; 21: 82-86.
57. Barclay MNI, Macpherson A: Selenium content of wheat flour used in the UK. J Sci Food and Agricul, 1986; 37(7): 1133-1138.
58. Anon: New Survey reveals massive drop in selenium consumption. Nutr Ther Today, 1995; 5(2): 1.
59. Kubota J, Allaway WH, Carter DL, et al: Selenium in crops in the United States in relation to selenium-responsive diseases in animals. J Agricul Food Chem, 1967; 15: 448-453.
60. US Department of Health, Education and Welfare, Public Health Service, National Institute of Mental Health, Survey and Reports Section, Biometry Branch: Patients in Mental Institutions 1965 Part II: State and County Mental Hospitals, PHSP No. 1597. Chevy Chase, Maryland. 1967.
61. Tan J, Li R, Zhu W: Medical geography. In: Geographical Society of China (ed). Recent development of geographical science in China. Beijing: Science Press. 1990: 259-279.
62. Berkel J, Bako G: Selenium and cancer: Overview and data from Alberta. Western Geographical Series, 1992; 27: 71-88.
63. Kok FJ, Hofman A, Witteman JCM, et al: Decreased selenium level in acute myocardial infarction. JAMA, 1989; 261(8): 1161-1164.
64. Tolonen M, Hulme M, Sarna S: Vitamin E and selenium supplementation in geriatric patients: a double-blind clinical trial. In: Combs GF Jr, Spallholz JE, Levander OA, Oldfield JE (eds). Selenium in Biology and Medicine Part B. New York: Van Nosttand Reinhold. 1987:
65. Krsnjavi H: Selenium and fertility in men. Trace Ele Med, 1992; 9(2): 107-108.
66. Foster HD: Disease family trees: the possible roles of iodine in goitre, cretinism, multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's and Parkinsons diseases and cancers of the thyroid, nervous system and skin. Med Hypoth, 1987; 24: 249-263.
67. Svistunova TB: Biogeochemical influences on the psychological development of school-children (in Kaschin-Beck areas). International Symposium on Environmental Life Elements and Health Abstracts. Beijing: Science Press. 1988: 283.
68. O'Reilly D, Murphy J, McLaughlin J, et al.: The prevalence of coeliac disease and cystic fibrosis in Ireland, Scotland, England and Wales. Int J Epidemiol, 1974; 3(3): 247-251.
69. McCarthy CF: Coeliac disease: its Irish dimensions. Irish J Med Sd, 1975; 144(1): 1-13.
70. Dohan FC, Harper EH, Clark MH, et al: Is schizophrenia rare if grain is rare? Biol Psychiat, 1984; 19(3): 305-399.
71. Cole SG, Kagnoff MF: Celiac disease. Ann. Rev. Nutr., 1985; 5: 241-266.
72. Dohan FC: Wheat "consumption" and hospital admissions for schizophrenics during World War II. A preliminary report. American J Clin Nutr, 1966; 18(1): 7-10.
73. Dohan FC: Cereals and schizophrenia. Data and hypotheses. Acta Psychiat Scand, 1966; 42: 125-152.
74. Pfeiffer CC: Schizophrenia and wheat gluten enteropathy. Biol Psychiat, 1984; 19(3): 279-80.
75. Perisic VN, Lopicic Z, Kokai G: Celiac disease and schizophrenia: family occurrence. J Pediat Gastr Nutr, 1990; 11: 279-287.
76. Cook WT, Holmes GKT: Neurological and psychiatric complications. In: Coeliac Disease, 1st Edition. Edinburgh: Churchill Livingstone. 1984: 195-213.
77. Bender L: Childhood schizophrenia. Psychiat Quart, 1953; 27: 3-81.
78. Dohan FC: Coeliac disease and schizophrenia. Lancet, 1970; I: 897-898.
79. Dohan FC: Coeliac disease and schizophrenia, Brit Med J, 1973; 3(870): 51-52.
80. Dickey W: Epilepsy, cerebral calcifications, and coeliac disease. Lancet, 1994; 1585-1586.
81. Templer D, Veleber DM: Schizophrenia prevalence: wheat, milk and temperature. J Orthomolecular Psychiat, 1980; 9(4): 284-286.
82. Singh MM, Kay SR: Wheat gluten as a pathogenic factor in schizophrenia. Science, 1976; 191: 401-402.
83. Lorenz K: Cereal allergies and intolerances. In: Tu AT (ed). Food Poisoning: Handbook of Natural Toxins 7. New York: Marcel Dekker. 1992: 373-398.
84. Hinks LJ, Inwards KD, Lloyd B, et al.: Body content of selenium in coeliac disease. British Med J, Clin Res Ed., 1984; 288(6434): 1862-1863.
85. Collins BJ, Bell PM, McMaster D, et al.: Selenium in coeliac disease. Brit Med J, Clin Res Ed., 1984; 289(6442): 439.
86. Cortigiani L, Nutini P, Caiulo VA, et al.: Selenium in celiac disease. Minerva Pediatrica, 1989; 41(11): 539-542 [Italian].
87. Foster HD: Reducing cancer mortality: A geographical perspective. Western Geographical Series 23. Victoria: Department of Geography, University of Victoria. 1986.
88. Norie IH, Foster HD: Water quality and cancer of the digestive tract: Canadian experience. J Orthomolecular Med, 1989; 4(2): 59-69.
89. Blot WJ, Li JY, Taylor PR, et al.: Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence and disease-specific mortality in the general population. J Nat Cancer Inst, 1993; 85: 1483-1492.
90. Yu W, Foster HD: Reducing the incidence of cancer of the esophagus: field evidence of the efficacy of jiangshi, a traditional Chinese stone drug. J Orthomolecular Med, 1991; 6(2): 57-63.
91. Templer DI, Hughey BB, Chalgujian H, et al.: Multiple sclerosis, schizophrenia, temperature and latitude. J Orthomolecular Med, 1990; 5(3): 125-128.
92. Foster HD: Schizophrenia and esophageal cancer: Comments on similarities in their spatial distributions. J Orthomolecular Med, 1990; 5(3): 129-134.
93. Mason TJ, McKay FW, Hoover R, et al: Atlas of Cancer Mortality for US Counties: 1950-1969. DHEW Publication No (NIH) 75-780. US Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, Bethesda, Maryland. 1975.
94. Campbell AMG, Crow RS, Lang DW: Goitre and disseminated sclerosis. Brit Med J, 1960; 1: 200-201.
95. Stevens JR: Schizophrenia and multiple sclerosis. Schizophrenia Bulletin, 1988; 14: 231-241.
96. Foster HD: Reducing the incidence of multiple sclerosis. Environments, 1988; 19(3): 14-34.
97. Spallholz JE: Selenium: What role in immunity and immune cytotoxicity. In: Spallholz JE, Martin JL, Ganther HE (eds). Selenium in Biology and Medicine. Westport: Avi Publishing. 1981: 103-117.
98. Johnson RT: The virology of demyelinating diseases. Ann. Neurol, 1994; 36: S54-S60.
99. Brown JS Jr: Geographic correlation of schizophrenia to ticks and tick-borne encephalitis. Schizophrenia Bulletin, 1994; 20: 755-775.
100. Poser CM: The epidemiology of multiple sclerosis: a general overview. Ann. Neurol 1994; 36(S2): S180-S193.
101. FDA: Drug Bulletin, 1984; 14: 19.
102. Snodgrass W, Rumach FBH, Sullivan JB Jr, et al.: Selenium: Childhood poisoning and cystic fibrosis. Clin Toxicol, 1981; 18(2): 211-220.
103. Van Campen DR: Trace elements in human nutrition. In: Mortvedt JJ, Cox FR, Shuman LM, Welch RM (eds). Micronutrients in Agriculture 2nd edition. Madison, Wisconsin: Soil Sci Soc Am, Inc. 1991: 663-701.
104. Schrauzer GN: Selenium and cancer: Historical developments and perspectives. In: Spallholz JE, Martin JL, Ganther HE (eds). Selenium in Biology and Medicine. Westport: Avi Publishing. 1981: 98-102.
105. Birt DF, Pour PM, Pelling JC: The influence of dietary selenium on colon, pancreas, and skin tumorigencsis. In: Wendel A (ed). Selenium in Biology and Medicine. Berlin: Springer-Verlag. 1989: 297-304.
106. McNeil TF, Blennow G, Lundberg L: Congenital malformations and structural development anomalies in groups at high risk for psychosis. Am J Psychiat, 1992; 149: 57-61.
107. McNeil TF Cantor-Graae E, Nordstrom LG, et al: Head circumference in "preschizophrenic" and control neonates. Brit J Psychiat 1993; 162: 517-523.